A decade after the first genome-wide association study in rheumatoid arthritis (RA), a
plethora of genetic association studies have been published on RA and its clinical or …

Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects~ 1% of the
Caucasian population. Over the last decades, the availability of biological drugs targeting …

With its comprehensive, global coverage of all aspects of diagnosis, screening, and
treatment in both adults and children, Firestein & Kelley's Textbook of Rheumatology …

Recent innovation in high-throughput sequencing technologies has drastically empowered
the scientific research. Consequently, now, it is possible to capture comprehensive profiles …

Rheumatoid arthritis (RA), one of the most common immune system diseases, mainly affects
middle-aged and elderly individuals and has a serious impact on the quality of life of …

Methotrexate and TNF-blocking agents are the DMARDs most commonly prescribed for the
treatment of rheumatoid arthritis (RA). However, not all patients treated with these …

Objective Biologic drug therapies represent a huge advance in the treatment of rheumatoid
arthritis (RA). However, very good disease control is achieved in only 30% of patients …

Individualising biologic disease-modifying anti-rheumatic drugs (bDMARDs) to maximise
outcomes and deliver safe and cost-effective care is a key goal in the management of …

Objective To aid in the selection of the most suitable therapeutic option in patients with
diagnosis of rheumatoid arthritis according to the phase of disease, through the review of …

Rheumatoid arthritis (RA) is characterised by chronic synovial joint inflammation. Treatment
has been revolutionised by tumour necrosis factor alpha inhibitors (TNFi) but each available …